Komori
S Foods (2292) · FactReframed

R&D expenditure

First written in FY2018-Q3. 23 of 31 entries say "Advanced", first in FY2018. Latest entry: FY2027-H1.

31entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018 – FY2020AdvancedFY2022-Q1 – FY2023-Q3AdvancedFY2024-Q1 – FY2025-H1ReframedFY2025 – FY2027-H12018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 420242025: 220252026: 12026
Same theme, other companies
Decrease in R&D expensesA theme 50 companies write about · 46 as a headwind · 4 as a tailwind

S Foods moved to the "Worse" side of this theme in 2025.

0 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 50 companies compared. The sentences above are computed from all 50.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1ReframedAnnual report

    「The total research and development expenses incurred by the group during the interim consolidated accounting period amounted to ¥130 million.」

    Research and development expenses for the interim period were ¥130 million, down from ¥162 million in the same period of the previous year.
  2. FY2026-H1ReframedAnnual report

    「The total research and development expenses incurred by the Group during the current interim consolidated accounting period were ¥162 million.」

    Research and development expenses for the interim period were ¥162 million, down from ¥190 million in the same period of the previous year.
  3. FY2025ReframedAnnual report

    「The total research and development expenses incurred by the Group during the fiscal year were ¥320 million.」

    Full-year research and development expenses were ¥320 million, down from ¥345 million in the previous fiscal year.
  4. FY2025-H1AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the current interim consolidated accounting period were ¥190 million.」

    Research and development expenses for the interim period were ¥190 million, exceeding ¥144 million in the same period of the previous year.
  5. FY2025-Q1AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the first quarter of the current consolidated cumulative period were ¥93 million.」

    Research and development expenses for the first quarter were ¥93 million, up from ¥68 million in the same period of the previous year.
  6. FY2024AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the fiscal year were ¥345 million.」

    Full-year research and development expenses were ¥345 million, up from ¥228 million in the previous fiscal year.
  7. FY2024-Q3AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the third quarter of the current consolidated cumulative period were ¥216 million.」

    Research and development expenses for the third quarter of the consolidated cumulative period were ¥216 million, exceeding ¥180 million in the same period of the previous year.
  8. FY2024-Q2AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the second quarter of the current consolidated cumulative period were ¥144 million.」

    Research and development expenses for the second quarter of the consolidated cumulative period were ¥144 million, exceeding ¥116 million in the same period of the previous year.
  9. FY2024-Q1AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the first quarter of the current consolidated cumulative period were ¥68 million.」

    Research and development expenses for the first quarter were ¥68 million, up from ¥58 million in the same period of the previous year.
  10. FY2023ReframedAnnual report

    「The total research and development expenses incurred by the Group during the fiscal year were ¥228 million.」

    Full-year research and development expenses were ¥228 million, down from ¥235 million in the previous fiscal year.
  11. FY2023-Q3AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the third quarter of the current consolidated cumulative period were ¥180 million.」

    Research and development expenses for the third quarter of the consolidated cumulative period were ¥180 million, exceeding ¥177 million in the same period of the previous year.
  12. FY2023-Q2AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the second quarter of the current consolidated cumulative period were ¥116 million.」

    Research and development expenses for the cumulative second quarter of fiscal year 57 were ¥116 million, the same as in the same period of the previous year.
  13. FY2023-Q1AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the first quarter of the current consolidated cumulative period were ¥58 million.」

    Research and development expenses for the first quarter were ¥58 million, up from ¥53 million in the same period of the previous year.
  14. FY2022AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the fiscal year were ¥235 million.」

    Full-year research and development expenses were ¥235 million, up from ¥199 million in the previous fiscal year.
  15. FY2022-Q3AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the third quarter of the current consolidated cumulative period were ¥177 million.」

    Research and development expenses for the third quarter of the consolidated cumulative period were ¥177 million, exceeding ¥160 million in the same period of the previous year and ¥116 million in the preceding cumulative quarter.
  16. FY2022-Q2AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the second quarter of the current consolidated cumulative period were ¥116 million.」

    Research and development expenses for the second quarter of the consolidated cumulative period were ¥116 million, up from ¥98 million in the same period of the previous year.
  17. FY2022-Q1AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the first quarter of the current consolidated cumulative period were ¥53 million.」

    Research and development expenses for the first quarter of the current consolidated cumulative period were disclosed as ¥53 million, up from ¥47 million in the same period of the previous year.
  18. FY2021ReframedAnnual report

    「The total research and development expenses incurred by the Group during the fiscal year were ¥199 million.」

    Full-year research and development expenses were ¥199 million, down from ¥223 million in the previous fiscal year.
  19. FY2021-Q3ReframedAnnual report

    「Depreciation and amortization ¥3,734 million」

    Research and development expenses for the third quarter of the current consolidated cumulative period were ¥152 million, below the ¥160 million recorded in the same period of the previous year. The cited passage is based on the research and development expense disclosure in the main text.
  20. FY2021-Q2AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the second quarter of the current consolidated cumulative period were ¥98 million.」

    Research and development expenses for the second quarter of the consolidated cumulative period were disclosed as ¥98 million.
  21. FY2021-Q1ReframedAnnual report

    「The total research and development expenses incurred by the Group during the first quarter of the current consolidated cumulative period were ¥47 million.」

    Research and development expenses decreased from ¥59 million in the same period of the previous year to ¥47 million.
  22. FY2020AdvancedAnnual report

    「The total research and development expenses incurred by the Group during the fiscal year were ¥223 million.」

    The full-year total research and development expenses were disclosed as ¥223 million.
  23. FY2020-Q3AdvancedAnnual report

    「The total research and development expenses incurred by our group during the nine months ended the third quarter of the current consolidated fiscal year were ¥176 million.」

    Total research and development expenses for the nine months ended the third quarter of the consolidated fiscal year were stated as ¥176 million.
  24. FY2020-Q2AdvancedAnnual report

    「The total research and development expenses incurred by our group during the six months ended the second quarter of the current consolidated fiscal year were ¥117 million.」

    Total research and development expenses for the six months ended the second quarter of the consolidated fiscal year were stated as ¥117 million.
  25. FY2020-Q1AdvancedAnnual report

    「The total research and development expenses incurred by our group during the three months ended the first quarter of the current consolidated fiscal year were ¥59 million.」

    Research and development expenses for the first quarter of the current consolidated fiscal year were stated as ¥59 million.
  26. FY2019AdvancedAnnual report

    「The total research and development expenses incurred by our group during the current consolidated fiscal year were ¥213 million.」

    Full-year research and development expenses were stated as ¥213 million.
  27. FY2019-Q3AdvancedAnnual report

    「The total research and development expenses incurred by our group during the nine months ended the third quarter of the current consolidated fiscal year were ¥160 million.」

    Total research and development expenses for the nine months ended the third quarter of the consolidated fiscal year were stated as ¥160 million.
  28. FY2019-Q2AdvancedAnnual report

    「The total research and development expenses incurred by our group during the six months ended the second quarter of the current consolidated fiscal year were ¥106 million.」

    Research and development expenses for the six months ended the second quarter of the consolidated fiscal year were stated as ¥106 million.
  29. FY2019-Q1AdvancedAnnual report

    「The total research and development expenses incurred by our group during the three months ended the first quarter of the current consolidated fiscal year were ¥54 million.」

    Research and development expenses for the first quarter of the current consolidated fiscal year were stated as ¥54 million.
  30. FY2018AdvancedAnnual report

    「The total research and development expenses incurred by our group during the current consolidated fiscal year were ¥202 million.」

    Full-year research and development expenses were stated as ¥202 million.
  31. FY2018-Q3First statedAnnual report

    「The total research and development expenses incurred by our group during the nine months ended the third quarter of the current consolidated fiscal year were ¥151 million.」

    Research and development expenses for the nine months ended the third quarter of the consolidated fiscal year were stated as ¥151 million.
Moved together

"Payment of dividends on common shares" moved the same way as this thread, in the same document, in 23 of its 31 moves.

231916151211★123456
  1. ★This thread
  2. 1Payment of dividends on common shares23×
  3. 2Increase in total assets and net assets19×
  4. 3Increase in liabilities due to higher trade payables and borrowings16×
  5. 4Increase in Guarantees of Obligations to Affiliated Companies, etc.15×
  6. 5Revenue and profit growth in the meat manufacturing and wholesale business12×
  7. 6Restaurant Business: Declining Revenue and Profit11×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for S Foods yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
R&D expenditure | S Foods Inc. (2292) | Komori